Literature DB >> 15051213

Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.

Mario A Di Pascuale1, Eiki Goto, Scheffer C G Tseng.   

Abstract

PURPOSE: The lipid tear film stabilizes the tears by lowering the surface tension and preventing aqueous tear evaporation and may be analyzed by kinetic analysis of the tear interference images. This study investigated changes in the lipid film after application of a new emulsion-based eye drop of Refresh Endura (Allergan, Irvine, CA) in normal subjects and patients with dry eyes.
DESIGN: Comparative, nonrandomized interventional study. PARTICIPANTS: Five normal subjects and 10 aqueous tear deficiency (ATD) patients with or without lipid tear deficiency were enrolled prospectively.
METHODS: A complete eye examination was performed, including symptom score, tear break-up time, dye staining, and fluorescein clearance test. One eye received a single dose of emulsion eye drop (EED), whereas the other eye received nonpreserved saline as a control. Kinetic analysis of tear interference images taken by DR-1 (Kowa, Japan) was performed before and at various times after instillation of the drops. MAIN OUTCOME MEASURES: Symptoms, pattern, thickness, and spread time of the tear film.
RESULTS: Compared with the control, all eyes receiving EED showed rapid restructuring of the preexisting lipid film. In normal persons, restructuring resulted in a thick lipid band across the cornea and a significant increase of the lipid film thickness. For ATD patients, EED application resulted in either a scant, irregular tear film, which became covered by the lipid film, or a modified lipid film changed without forming a band or irregularities. Emulsion eye drops tended to be more comfortable in patients with more severe ATD. Kinetic analysis showed that the mean spread time improved for all patients after EED when compared with baseline or with controls (P<0.05).
CONCLUSIONS: Emulsion eye drop produces significant changes in the tear film of normal and dry eye patients. Further investigation with a prolonged period of treatment is warranted to establish whether EED may help improve the spread and thickness of the lipid tear film in moderate and severe dry eyes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051213     DOI: 10.1016/j.ophtha.2003.07.008

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Coadsorption of human milk lactoferrin into the dipalmitoylglycerolphosphatidylcholine phospholipid monolayer spread at the air/water interface.

Authors:  Fausto Miano; Xiubo Zhao; Jian R Lu; Jeff Penfold
Journal:  Biophys J       Date:  2006-11-17       Impact factor: 4.033

2.  Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.

Authors:  P Prabhasawat; N Tesavibul; N Kasetsuwan
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

Review 3.  Four characteristics and a model of an effective tear film lipid layer (TFLL).

Authors:  P Ewen King-Smith; Melissa D Bailey; Richard J Braun
Journal:  Ocul Surf       Date:  2013-07-12       Impact factor: 5.033

Review 4.  The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.

Authors:  Gerd Geerling; Joseph Tauber; Christophe Baudouin; Eiki Goto; Yukihiro Matsumoto; Terrence O'Brien; Maurizio Rolando; Kazuo Tsubota; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

5.  Prevalence, risk factors, and morbidity of eye lid laxity in a veteran population.

Authors:  Zubair Ansari; Roshni Singh; Chrisfouad Alabiad; Anat Galor
Journal:  Cornea       Date:  2015-01       Impact factor: 2.651

6.  High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.

Authors:  Mohammad H Dastjerdi; Pedram Hamrah; Reza Dana
Journal:  Cornea       Date:  2009-12       Impact factor: 2.651

Review 7.  Pharmacological management of dry eye in the elderly patient.

Authors:  Gary N Foulks
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

8.  The challenge of dry eye diagnosis.

Authors:  Giacomo Savini; Pinita Prabhawasat; Takashi Kojima; Martin Grueterich; Edgar Espana; Eiki Goto
Journal:  Clin Ophthalmol       Date:  2008-03

9.  Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits.

Authors:  H Liang; F Brignole-Baudouin; L Rabinovich-Guilatt; Z Mao; L Riancho; M O Faure; J M Warnet; G Lambert; C Baudouin
Journal:  Mol Vis       Date:  2008-01-31       Impact factor: 2.367

10.  Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial.

Authors:  Peter A Simmons; Cindy Carlisle-Wilcox; Joseph G Vehige
Journal:  Clin Ophthalmol       Date:  2015-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.